Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients

<p>Abstract</p> <p>Oculopharyngeal muscular dystrophy (OPMD) is a late-onset progressive muscle disorder caused by a poly-alanine expansion mutation in the Poly(A) Binding Protein Nuclear 1 (PABPN1). The molecular mechanisms that regulate disease onset and progression are largely u...

Full description

Bibliographic Details
Main Authors: Anvar Seyed, 't Hoen Peter AC, Venema Andrea, van der Sluijs Barbara, van Engelen Baziel, Snoeck Marc, Vissing John, Trollet Capucine, Dickson George, Chartier Aymeric, Simonelig Martine, van Ommen Gert-Jan B, van der Maarel Silvere M, Raz Vered
Format: Article
Language:English
Published: BMC 2011-04-01
Series:Skeletal Muscle
Online Access:http://www.skeletalmusclejournal.com/content/1/1/15
id doaj-8c74646d6e7c44c8b4ee02757f470484
record_format Article
spelling doaj-8c74646d6e7c44c8b4ee02757f4704842020-11-24T22:06:38ZengBMCSkeletal Muscle2044-50402011-04-01111510.1186/2044-5040-1-15Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patientsAnvar Seyed't Hoen Peter ACVenema Andreavan der Sluijs Barbaravan Engelen BazielSnoeck MarcVissing JohnTrollet CapucineDickson GeorgeChartier AymericSimonelig Martinevan Ommen Gert-Jan Bvan der Maarel Silvere MRaz Vered<p>Abstract</p> <p>Oculopharyngeal muscular dystrophy (OPMD) is a late-onset progressive muscle disorder caused by a poly-alanine expansion mutation in the Poly(A) Binding Protein Nuclear 1 (PABPN1). The molecular mechanisms that regulate disease onset and progression are largely unknown. In order to identify molecular pathways that are consistently associated with OPMD, we performed an integrated high-throughput transcriptome study in affected muscles of OPMD animal models and patients. The ubiquitin-proteasome system (UPS) was found to be the most consistently and significantly OPMD-deregulated pathway across species. We could correlate the association of the UPS OPMD-deregulated genes with stages of disease progression. The expression trend of a subset of these genes is age-associated and therefore, marks the late onset of the disease, and a second group with expression trends relating to disease-progression. We demonstrate a correlation between expression trends and entrapment into PABPN1 insoluble aggregates of OPMD-deregulated E3 ligases. We also show that manipulations of proteasome and immunoproteasome activity specifically affect the accumulation and aggregation of mutant PABPN1. We suggest that the natural decrease in proteasome expression and its activity during muscle aging contributes to the onset of the disease.</p> http://www.skeletalmusclejournal.com/content/1/1/15
collection DOAJ
language English
format Article
sources DOAJ
author Anvar Seyed
't Hoen Peter AC
Venema Andrea
van der Sluijs Barbara
van Engelen Baziel
Snoeck Marc
Vissing John
Trollet Capucine
Dickson George
Chartier Aymeric
Simonelig Martine
van Ommen Gert-Jan B
van der Maarel Silvere M
Raz Vered
spellingShingle Anvar Seyed
't Hoen Peter AC
Venema Andrea
van der Sluijs Barbara
van Engelen Baziel
Snoeck Marc
Vissing John
Trollet Capucine
Dickson George
Chartier Aymeric
Simonelig Martine
van Ommen Gert-Jan B
van der Maarel Silvere M
Raz Vered
Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
Skeletal Muscle
author_facet Anvar Seyed
't Hoen Peter AC
Venema Andrea
van der Sluijs Barbara
van Engelen Baziel
Snoeck Marc
Vissing John
Trollet Capucine
Dickson George
Chartier Aymeric
Simonelig Martine
van Ommen Gert-Jan B
van der Maarel Silvere M
Raz Vered
author_sort Anvar Seyed
title Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
title_short Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
title_full Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
title_fullStr Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
title_full_unstemmed Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
title_sort deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in opmd animal models and patients
publisher BMC
series Skeletal Muscle
issn 2044-5040
publishDate 2011-04-01
description <p>Abstract</p> <p>Oculopharyngeal muscular dystrophy (OPMD) is a late-onset progressive muscle disorder caused by a poly-alanine expansion mutation in the Poly(A) Binding Protein Nuclear 1 (PABPN1). The molecular mechanisms that regulate disease onset and progression are largely unknown. In order to identify molecular pathways that are consistently associated with OPMD, we performed an integrated high-throughput transcriptome study in affected muscles of OPMD animal models and patients. The ubiquitin-proteasome system (UPS) was found to be the most consistently and significantly OPMD-deregulated pathway across species. We could correlate the association of the UPS OPMD-deregulated genes with stages of disease progression. The expression trend of a subset of these genes is age-associated and therefore, marks the late onset of the disease, and a second group with expression trends relating to disease-progression. We demonstrate a correlation between expression trends and entrapment into PABPN1 insoluble aggregates of OPMD-deregulated E3 ligases. We also show that manipulations of proteasome and immunoproteasome activity specifically affect the accumulation and aggregation of mutant PABPN1. We suggest that the natural decrease in proteasome expression and its activity during muscle aging contributes to the onset of the disease.</p>
url http://www.skeletalmusclejournal.com/content/1/1/15
work_keys_str_mv AT anvarseyed deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT thoenpeterac deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT venemaandrea deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT vandersluijsbarbara deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT vanengelenbaziel deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT snoeckmarc deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT vissingjohn deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT trolletcapucine deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT dicksongeorge deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT chartieraymeric deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT simoneligmartine deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT vanommengertjanb deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT vandermaarelsilverem deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
AT razvered deregulationoftheubiquitinproteasomesystemisthepredominantmolecularpathologyinopmdanimalmodelsandpatients
_version_ 1725822730494803968